自2015年起，我们一直跟顺势疗法研究院(Homeopathy ResearchInstitute, HRI) (https://www.hri-research.org/resources/homeopathy-faqs/)合作。

除了紧贴世界最新的顺势疗法科研之外，总裁杜家麟院士带领专业团队与香港中文大学合作，于2012至2016年间进行顺势疗法处理糖尿病的队列研究，并已通过同行评审及出版。

To,K. L. A., Fok, Y. Y. Y., Chong, K. C. M., Lee, Y. C. J., & Yiu, L. S. S.(2017).Individualized homeopathic treatment in addition to conventional treatment intype II diabetic patients in Hong Kong–a retrospective cohort study.Homeopathy,106(02), 79-86.

2017年杜家麟院士亦已开始跟顺势疗法研究院系统综述团队合作，进行为期三年的一系列系统性综述(Systematic Review)，陆续经同行评审及出版。

Mathie, R. T., Fok, Y. Y., Viksveen, P., To, A. K., & Davidson, J. R. (2019). Systematicreview and meta-analysis of randomised, other-than-placebo controlled, trials ofnon-individualised homeopathic treatment.Homeopathy, 108(02), 088-101.

2019年，全球新冠肺炎(Covid)大流行，杜家麟院士就活跃于相关的科学研究项目，首先是出版了全球第一个COVID-19的顺势疗法个案系列，更获世界卫生组织数据库收录：To, K. L. A., & Fok, Y. Y. Y. (2020). Homeopathic clinical features of 18 patients inCOVID-19 outbreaks in Hong Kong.Homeopathy, 109(03), 146-162.（注3）注3：WHO已于2024年1月，将「全球新冠文献数据库」封存。

之后，在本地的第一波爆发及OMICRON爆发时，为顺势疗法专业作出贡献，令全球同行均可受益，并肩在此前所未见的疫症中砥砺前行。

Tournier, A., Fok, Y., van Haselen, R., & To, A. (2023). Homeopathic Treatment ofCOVID-19 Patients: Findings of the Clificol International Clinical Case Registry.Integrative Medicine Reports, 2(1), 87-96.

Tournier, A., Fok, Y., van Haselen, R., & To, A. (2024). The SymptomaticExpression in Chinese Patients with Suspected COVID-19 Omicron VariantInfection: A Clinical Case Registry Study. OBM Integrative and ComplementaryMedicine, 9(3), 1-26.

• 科研出版：中国疑似COVID-19 Omicron变异感染患者的症状表现：临床病例登记研究
• Tournier, A., Fok, Y., van Haselen, R., & To, A. (2024). The SymptomaticExpression in Chinese Patients with Suspected COVID-19 Omicron VariantInfection: A Clinical Case Registry Study. OBM Integrative and ComplementaryMedicine, 9(3), 1-26.

• 10/04科研出版：COVID-19患者的顺势疗法治疗：Clificol国际临床病例注册的结果。Tournier, A., Fok, Y., van Haselen, R., & To, A. (2023). Homeopathic Treatment ofCOVID-19 Patients: Findings of the Clificol International Clinical Case Registry.Integrative Medicine Reports, 2(1), 87-96.

2022/

• 10/02科研出版：寻找中国患者的流行特效疗剂：来自ClificolCOVID-19临床病例记录库的发现Tournier, A., Fok, Y., van Haselen, R., &To, A. (2023). Searching for the genus epidemicus in Chinese patients:findings from the Clificol COVID-19 Clinical Case Registry.Homeopathy,112(01), 030-039.

2021/

• 04/06科研出版：来自中国的更新：大规模疫情中顺势疗法的临床和研究To, K. L. A., & Fok, Y. Y. Y. (2021). Updates from China: clinical and researchexperience of homeopathy in the pandemic. International Journal of HighDilution Resarch, 20(1).

2020/

• 06/05科研出版：香港COVID-19疫情中18例患者的顺势疗法临床特征

• To, K. L. A., & Fok, Y. Y. Y. (2020). Homeopathic clinical features of 18 patients inCOVID-19 outbreaks in Hong Kong.Homeopathy,109(03), 146-162.

• 01/30科研出版：随机顺势疗法非个人化、非安慰剂对照试验的系统评价及荟萃分析Mathie, R. T., Fok, Y. Y., Viksveen, P., To, A. K., & Davidson, J. R. (2019). Systematicreview and meta-analysis of randomised, other-than-placebo controlled, trials ofnon-individualised homeopathic treatment.Homeopathy,108(02), 088-101.

• 03/17科研出版：在香港于二型糖尿病人的常规治疗上加入个人化顺势疗法处理——回顾性队列研究To, K. L. A., Fok, Y. Y. Y., Chong, K. C.M., Lee, Y. C. J., & Yiu, L. S. S. (2017). Individualized homeopathictreatment in addition to conventional treatment in type II diabetic patientsin HongKong–a retrospective cohort study.Homeopathy,106(02),79-86.